| Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group Lancet (London, England) 397 (10285), 1637, 2021 | 2506* | 2021 |
| Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial LA Guay, P Musoke, T Fleming, D Bagenda, M Allen, C Nakabiito, ... The Lancet 354 (9181), 795-802, 1999 | 2405 | 1999 |
| Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission PM Garcia, LA Kalish, J Pitt, H Minkoff, TC Quinn, SK Burchett, J Kornegay, ... New England Journal of Medicine 341 (6), 394-402, 1999 | 1077 | 1999 |
| Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre … APS Munro, L Janani, V Cornelius, PK Aley, G Babbage, D Baxter, M Bula, ... The Lancet 398 (10318), 2258-2276, 2021 | 737 | 2021 |
| Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-month follow-up of the … JB Jackson, P Musoke, T Fleming, LA Guay, D Bagenda, M Allen, ... The Lancet 362 (9387), 859-868, 2003 | 706 | 2003 |
| The relation of virologic and immunologic markers to clinical outcomes after nucleoside therapy in HIV-infected adults with 200 to 500 CD4 cells per cubic millimeter DA Katzenstein, SM Hammer, MD Hughes, H Gundacker, JB Jackson, ... New England Journal of Medicine 335 (15), 1091-1098, 1996 | 578 | 1996 |
| Thalidomide for the treatment of oral aphthous ulcers in patients with human immunodeficiency virus infection JM Jacobson, JS Greenspan, J Spritzler, N Ketter, JL Fahey, JB Jackson, ... New England Journal of Medicine 336 (21), 1487-1493, 1997 | 560 | 1997 |
| Selection and fading of resistance mutations in women and infants receiving nevirapine to prevent HIV-1 vertical transmission (HIVNET 012) SH Eshleman, M Mracna, LA Guay, M Deseyve, S Cunningham, ... Aids 15 (15), 1951-1957, 2001 | 549 | 2001 |
| Intermittent HIV-1 viremia (Blips) and drug resistance in patients receiving HAART RE Nettles, TL Kieffer, P Kwon, D Monie, Y Han, T Parsons, ... Jama 293 (7), 817-829, 2005 | 490 | 2005 |
| Safety, pharmacokinetics, and antiviral activity of AMD3100, a selective CXCR4 receptor inhibitor, in HIV-1 infection CW Hendrix, AC Collier, MM Lederman, D Schols, RB Pollard, S Brown, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 37 (2), 1253-1262, 2004 | 459 | 2004 |
| Cost effectiveness of single-dose nevirapine regimen for mothers and babies to decrease vertical HIV-1 transmission in sub-Saharan Africa E Marseille, JG Kahn, F Mmiro, L Guay, P Musoke, MG Fowler, ... The Lancet 354 (9181), 803-809, 1999 | 375 | 1999 |
| Identification of the K103N resistance mutation in Ugandan women receiving nevirapine to prevent HIV-1 vertical transmission JB Jackson, G Becker-Pergola, LA Guay, P Musoke, M Mracna, ... Aids 14 (11), F111-F115, 2000 | 289 | 2000 |
| A phase I/II study of the safety and pharmacokinetics of nevirapine in HIV-1-infected pregnant Ugandan women and their neonates (HIVNET 006) P Musoke, LA Guay, D Bagenda, M Mirochnick, C Nakabiito, T Fleming, ... Aids 13 (4), 479-486, 1999 | 262 | 1999 |
| Association of plasma human immunodeficiency virus type 1 RNA level with risk of clinical progression in patients with advanced infection RW Coombs, SL Welles, C Hooper, PA Reichelderfer, RT D'Aquila, ... Journal of Infectious Diseases 174 (4), 704-712, 1996 | 232 | 1996 |
| Sensitive drug-resistance assays reveal long-term persistence of HIV-1 variants with the K103N nevirapine (NVP) resistance mutation in some women and infants after the … T Flys, DV Nissley, CW Claasen, D Jones, C Shi, LA Guay, P Musoke, ... The Journal of infectious diseases 192 (1), 24-29, 2005 | 231 | 2005 |
| Diagnostic utility of telomere length testing in a hospital-based setting JK Alder, VS Hanumanthu, MA Strong, AE DeZern, SE Stanley, ... Proceedings of the National Academy of Sciences 115 (10), E2358-E2365, 2018 | 228 | 2018 |
| Nevirapine (NVP) resistance in women with HIV-1 subtype C, compared with subtypes A and D, after the administration of single-dose NVP SH Eshleman, DR Hoover, S Chen, SE Hudelson, LA Guay, A Mwatha, ... The Journal of infectious diseases 192 (1), 30-36, 2005 | 226 | 2005 |
| Extended-dose nevirapine to 6 weeks of age for infants to prevent HIV transmission via breastfeeding in Ethiopia, India, and Uganda: an analysis of three randomised controlled … SWEDNS Study The Lancet 372 (9635), 300-313, 2008 | 221 | 2008 |
| Multicenter evaluation of use of dried blood and plasma spot specimens in quantitative assays for human immunodeficiency virus RNA: measurement, precision, and RNA stability D Brambilla, C Jennings, G Aldrovandi, J Bremer, AM Comeau, ... Journal of Clinical Microbiology 41 (5), 1888-1893, 2003 | 210 | 2003 |
| Coreceptor tropism in human immunodeficiency virus type 1 subtype D: high prevalence of CXCR4 tropism and heterogeneous composition of viral populations W Huang, SH Eshleman, J Toma, S Fransen, E Stawiski, EE Paxinos, ... Journal of virology 81 (15), 7885-7893, 2007 | 209 | 2007 |
